Analyst Rating: Will Sesen Bio Inc (SESN) Stock Do Better Than the Market?

Monday, October 18, 2021 02:10 PM | InvestorsObserver Analysts

Mentioned in this article

Wall Street is positive on Sesen Bio Inc (SESN). On average, analysts give SESN a Buy rating. The average price target is $4.25, which means analysts expect the stock to gain by 356.99% over the next twelve months. That average ranking earns SESN an Analyst Rating of 20, which is better than 20% of stocks based on data compiled by InvestorsObserver.

Wall Street analysts are rating SESN a Buy today. Find out what this means to you and get the rest of the rankings on SESN!
See Full SESN Report

Why are Analyst Ratings Important?

A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement. InvestorsObserver averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.

What's Happening With Sesen Bio Inc Stock Today?

Sesen Bio Inc (SESN) stock is lower by -3.36% while the S&P 500 is higher by 0.19% as of 2:09 PM on Monday, Oct 18. SESN is down -$0.03 from the previous closing price of $0.96 on volume of 5,455,579 shares. Over the past year the S&P 500 is up 30.72% while SESN is down -16.96%. SESN lost -$0.80 per share the over the last 12 months. Click Here to get the full Stock Report for Sesen Bio Inc stock.

Share this article:

Related Articles